Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HOLOCORE long-term extension follow-up after Holoclar transplantation
NL-OMON49307Phase 4Active, not recruiting
- Sponsor
- Holostem
- Start
- Jul 2019
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ex vivo reconstructed autologous human corneal epithelium containing stem cells in limbal stem cell deficiency (LSCD), sponsored by Holostem. Started Jul 2019; status: active, not recruiting.
02
Drugs
ex vivo reconstructed autologous human corneal epithelium containing stem cells
03
Conditions
limbal stem cell deficiency (LSCD)
Beyond the preview
Go deeper on NL-OMON49307.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON49307.